How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Veterinary Surgical Needle Market
- By Needle Type: Cutting Needle, Taper Point Needle, Reverse Cutting Needle, Blunt Point Needle, Trocar Point Needle
- By Needle Size: 6/0, 5/0, 4/0, 3/0, 2/0, 1
- By Needle Material: Stainless Steel, Titanium, Carbon Steel
- By Suture Compatibility: Monofilament Sutures, Multifilament Sutures, Absorbable Sutures, Non-absorbable Sutures
- By Application: Small Animal Surgery, Large Animal Surgery, Exotic Animal Surgery, Equine Surgery
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cutting Needle leads By Needle Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 301 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Veterinary Surgical Needle Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Needle Type 5
Needle Size 6
Needle Material 3
Suture Compatibility 4
Application 4
Companies profiled
B. Braun Melsungen AG
Medtronic plc
Stryker Corporation
Ethicon (Johnson & Johnson)
Smith & Nephew plc
Integra LifeSciences Holdings Corporation
Teleflex Incorporated
MediPurpose
Hu-Friedy Mfg. Co.
LLC
Aesculap AG (B. Braun)
Patterson Companies Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Ethicon (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Smith & Nephew plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Integra LifeSciences Holdings Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Teleflex Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →MediPurpose
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hu-Friedy Mfg. Co.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Aesculap AG (B. Braun)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Patterson Companies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Henry Schein Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Vetoquinol SA
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Zoetis Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Merial (now part of Boehringer Ingelheim)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,294M by 2033 · 7.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cutting Needle50.7
- Taper Point Needle10.4
- Reverse Cutting Needle14.7
- Blunt Point Needle13.9
- Trocar Point Needle10.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,505M → $2,929M · 8.7%
Europe$1,049M → $1,732M · 6.5%
Asia Pacific$957.7M → $1,809M · 8.3%
Latin America$592.8M → $1,166M · 8.8%
Middle East and Africa$456.0M → $879.7M · 8.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.712026
7.722027
7.752028
7.762029
7.762030
7.772031
7.792032
7.792033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- B. Braun Melsungen AG14.8
- Medtronic plc22.5
- Stryker Corporation9.8
- Ethicon (Johnson & Johnson)4.5
- Smith & Nephew plc15.2
- Integra LifeSciences Holdings Corporation5.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Needle Type27.2%
Needle Size25.7%
Needle Material19.2%
Suture Compatibility17.7%
Application10.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.4
- Europe20.3
- Asia Pacific21.2
- Latin America13.7
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | 91 | 93 | 91 | 93 | 96 | 76 | 90 |
| Medtronic plc | 79 | 78 | 87 | 89 | 76 | 79 | 81 |
| Stryker Corporation | 86 | 84 | 86 | 63 | 63 | 87 | 78 |
| Ethicon (Johnson & Johnson) | 62 | 82 | 58 | 61 | 63 | 61 | 65 |
| Smith & Nephew plc | 71 | 58 | 60 | 67 | 69 | 67 | 65 |
| Integra LifeSciences Holdings Corporation | 48 | 51 | 56 | 58 | 56 | 59 | 55 |
| Teleflex Incorporated | 50 | 52 | 55 | 53 | 54 | 56 | 53 |
| MediPurpose | 48 | 51 | 52 | 56 | 53 | 60 | 53 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- B. Braun Melsungen AG
- Medtronic plc
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Medtronic plc | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Stryker Corporation | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| Ethicon (Johnson & Johnson) | ◐ | ✓ | ◐ | − | ◐ | ◐ |
| Smith & Nephew plc | ◐ | ◐ | − | ◐ | ✓ | ✓ |
| Integra LifeSciences Holdings Corporation | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Teleflex Incorporated | − | − | − | − | − | ◐ |
| MediPurpose | ◐ | ◐ | ◐ | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1B. Braun Melsungen AG90
2Medtronic plc81
3Stryker Corporation78
4Ethicon (Johnson & Johnson)65
5Smith & Nephew plc65
6Integra LifeSciences Holdings Corporation55
7Teleflex Incorporated53
8MediPurpose53
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
B. Braun Melsungen AGMedtronic plcStryker Corporation
Contender2
Focused players with pockets of strength.
Ethicon (Johnson & Johnson)Smith & Nephew plc
Niche3
Specialists in a single segment or region.
Integra LifeSciences Holdings CorporationTeleflex IncorporatedMediPurpose
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Needle Type in North America, then scale across Veterinary Surgical Needle Market — a $537M beachhead inside a $9.67B market.
Beachhead (SOM)$537Mobtainable near-term
Serviceable (SAM)$3.53Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Cutting Needle
Best fit — highest urgency & budget in Needle Type.
Economic buyer76 fit
Taper Point Needle
Strong fit — clear ROI and a fast path to value.
End user68 fit
Reverse Cutting Needle
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Needle Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Needle Size & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Needle Material
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel26%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Needle Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Veterinary Surgical Needle Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation14%
Closed-won8%
$16.0KCAC
$88KLTV
5.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Veterinary Surgical Needle Market is a durable-growth opportunity — $2.29B by 2033, compounding at 8.5%.
TAM · 2025$1.19Btoday
TAM · 2033$2.29Bforecast
CAGR8.5%2027–2033
Cumulative$15.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.29BTotal addressable market
SAM$919MServiceable available market
SOM$160MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.5% CAGR
Demand compounds through 2033, outpacing GDP across Needle Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Needle Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.29BLarge & growingTAM by 2033 at 8.5% CAGR
$919MServiceable nowreachable with today’s model
$160MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.79BBear5.5% CAGR
$2.29BBase8.5% CAGR
$2.93BBull11.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Needle Size optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Veterinary Surgical Needle Market — a $1.46B market by 2033. Plan: grow share from 7.1% to 14.4%.
Market size · 2033$1.46Btotal addressable
Market CAGR4.0%2027–2033
Target share14.4%from 7.1% today
Revenue ambition$210Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.1% | 14.4% | Behind |
| Revenue | $94M | $210M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 28.2% | 38.1% | Ahead |
| Customer retention | 87.5% | 92.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Needle Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Needle Size capability
A defensible second engine — invest in Needle Size to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Needle Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Needle Size
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $22M capacity & capability investment
- Greenlight bolt-on M&A in Needle Size
- Authorise North America expansion plan
- Fund R&D program for Needle Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Veterinary Surgical Needle Market conversation — a $8.49B market you can size, segment and defend in minutes.
Market size · 2033$8.49Btotal opportunity
Growth6.9%CAGR to 2033
Addressable buyers1,465+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Needle Type
Goal Grow share in Needle Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 2 mopayback period
$63K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
B. Braun Melsungen AGMedtronic plcStryker CorporationEthicon (Johnson & Johnson)Smith & Nephew plcIntegra LifeSciences Holdings CorporationTeleflex IncorporatedMediPurpose+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Veterinary Surgical Needle Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Veterinary Surgical Needle Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Veterinary Surgical Handheld Devices Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportVeterinary Surgery Suture Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportVeterinary Surgery Scales Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportVeterinary Surgery Otoscope Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportVeterinary Surgery Laser Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportVeterinary Surgery High Frequency Electrosurgical Unit Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportVeterinary Surgery Endoscope Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportVeterinary Surgery Electrosurgical Units Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportVeterinary Sulfa Drugs Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportVeterinary Sulfadiazine API Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportVeterinary Stretcher Trolley Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportVeterinary Stretcher Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.